PURPOSE: Both genetic instability resulting in aneuploidy and increased proliferative activity are common features of tumor development and progression. Cytometric evaluation of tumor ploidy status was recently suggested as a prognostic marker. However, in prostate cancer (PCa), a chromosome-specific evaluation is lacking. With the present study, we sought to identify distinct chromosomal changes to complement cytometric results concerning the diagnosis and prognosis of PCa patients. METHODS: We assessed a cohort of 428 PCa specimens (186 localized PCa, 75 lymph node metastasized PCa, 125 lymph node metastases, 42 hormone-refractory distant metastases) for numerical alterations of all 24 chromosomes by using fluorescence in situ hybridization (FISH). Conducting immunohistochemistry with phosphorylated histone H3 (PHH3) and Ki-67, we quantified the proliferation rate. FISH results were fit in a linear model and tested for predictive power. RESULTS: As expected, we observed a significant increase in aneuploidy with advancing tumor stage. Similarly, an increased expression of the mitotic marker PHH3 was significantly associated with aneuploidy and higher pT-stage. We found aneusomy of chromosomes 4, 6, 20, and X to be indicative of lymph node metastasized PCa. However, with an AUC of 65%, this set of chromosomal changes was poorly suited to distinguish non-metastasized and lymph node metastasized primary tumors. CONCLUSION: Our results provide thorough insight into the so far incompletely elucidated chromosomal landscape of PCa. While overall ploidy status and PHH3 expression in primary tumors indicate advanced disease, a FISH-based test for distinct alterations does not seem to be beneficial for diagnostic or prognostic decisions.
PURPOSE: Both genetic instability resulting in aneuploidy and increased proliferative activity are common features of tumor development and progression. Cytometric evaluation of tumor ploidy status was recently suggested as a prognostic marker. However, in prostate cancer (PCa), a chromosome-specific evaluation is lacking. With the present study, we sought to identify distinct chromosomal changes to complement cytometric results concerning the diagnosis and prognosis of PCa patients. METHODS: We assessed a cohort of 428 PCa specimens (186 localized PCa, 75 lymph node metastasized PCa, 125 lymph node metastases, 42 hormone-refractory distant metastases) for numerical alterations of all 24 chromosomes by using fluorescence in situ hybridization (FISH). Conducting immunohistochemistry with phosphorylated histone H3 (PHH3) and Ki-67, we quantified the proliferation rate. FISH results were fit in a linear model and tested for predictive power. RESULTS: As expected, we observed a significant increase in aneuploidy with advancing tumor stage. Similarly, an increased expression of the mitotic marker PHH3 was significantly associated with aneuploidy and higher pT-stage. We found aneusomy of chromosomes 4, 6, 20, and X to be indicative of lymph node metastasized PCa. However, with an AUC of 65%, this set of chromosomal changes was poorly suited to distinguish non-metastasized and lymph node metastasized primary tumors. CONCLUSION: Our results provide thorough insight into the so far incompletely elucidated chromosomal landscape of PCa. While overall ploidy status and PHH3 expression in primary tumors indicate advanced disease, a FISH-based test for distinct alterations does not seem to be beneficial for diagnostic or prognostic decisions.
Authors: J S Ross; C E Sheehan; R A Ambros; T Nazeer; T A Jennings; R P Kaufman; H A Fisher; M D Rifkin; B V Kallakury Journal: Am J Surg Pathol Date: 1999-03 Impact factor: 6.394
Authors: Ivar Skaland; Emiel A M Janssen; Einar Gudlaugsson; Jan Klos; Kjell H Kjellevold; Håvard Søiland; Jan P A Baak Journal: Mod Pathol Date: 2007-10-05 Impact factor: 7.842
Authors: A Alcaraz; S Takahashi; J A Brown; J F Herath; E J Bergstralh; J J Larson-Keller; M M Lieber; R B Jenkins Journal: Cancer Res Date: 1994-08-01 Impact factor: 12.701
Authors: Antonio Alcaraz; Juan M Corral; María J Ribal; Carme Mallofré; Lourdes Mengual; Ana Carrió; José María Gil-Vernet Sedó; Humberto Villavicencio Journal: BJU Int Date: 2004-08 Impact factor: 5.588
Authors: Michael Nowak; Maria A Svensson; Jessica Carlsson; Wenzel Vogel; Moritz Kebschull; Nicolas Wernert; Glen Kristiansen; Ove Andrén; Martin Braun; Sven Perner Journal: World J Urol Date: 2013-07-26 Impact factor: 4.226